US Broker Ratings

Veeva Systems Inc. (VEEV) Stock Analysis: Evaluating Growth Potential with Revenue Surging 16.7%

Veeva Systems Inc. (NYSE: VEEV), a prominent provider of cloud-based software solutions tailored for the life sciences industry, continues to capture investor attention with its strong..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 13% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a substantial market capitalization..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Healthcare Giant with 59% Return on Equity

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of..

Mettler-Toledo International, Inc. (MTD): Investor Outlook with 7.75% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a key player in the healthcare sector’s diagnostics and research industry, stands as a formidable name in precision instruments and services...

Vertex Pharmaceuticals (VRTX) Stock Analysis: A $116 Billion Biotech Giant with 9.81% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leader in the biotechnology sector, offers a compelling opportunity for investors interested in healthcare innovation and growth. With a market..

ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, is capturing investor attention with its robust market presence in the medical instruments and supplies industry...

Bristol-Myers Squibb (BMY) Stock Analysis: Healthcare Giant with a 14.77% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY) remains a formidable player in the healthcare sector, boasting a market capitalization of $101.25 billion. The company is a global leader..

Becton, Dickinson and Company (BDX) Stock Analysis: Uncovering a 28.77% Upside Potential in the Healthcare Giant

Investors eyeing Becton, Dickinson and Company (NYSE: BDX) may find themselves intrigued by the potential upside of nearly 29%, especially in a sector as robust and..

CVS Health Corporation (CVS) Stock Analysis: A 17.83% Upside Potential with Solid Dividend Yield

CVS Health Corporation (NYSE: CVS) continues to be a significant player in the healthcare sector, operating with a market capitalization of $85.34 billion. As a multifaceted..

Eli Lilly and Company (LLY) Stock Analysis: Unpacking a 16% Potential Upside for Investors

Eli Lilly and Company (NYSE: LLY) continues to solidify its position as a titan in the pharmaceutical industry, presenting a compelling opportunity for investors seeking growth..

AbbVie Inc. (ABBV) Stock Analysis: A 9.31% Upside Amid Strong Dividend Yield and Robust Pipeline

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, commands a formidable market presence with its $337.52 billion market capitalization. As a key player in..

Abbott Laboratories (ABT) Stock Analysis: Navigating Growth in Healthcare with a Strong Dividend Yield

Abbott Laboratories (NYSE: ABT) continues to be a stalwart in the healthcare sector, leveraging its vast portfolio of medical devices, diagnostic products, and nutritional offerings. With..

Intuitive Surgical (ISRG) Stock Analysis: Exploring a 12.36% Potential Upside Amid Robust Growth

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading innovator in the healthcare sector, continues to attract investor interest with its pioneering advancements in minimally invasive surgical technologies...

Stryker Corporation (SYK) Stock Analysis: Uncovering an 11.7% Potential Upside in the Healthcare Sector

Stryker Corporation (NYSE: SYK), a leader in the healthcare sector specializing in medical devices, continues to capture investor attention with its robust market presence and promising..

Boston Scientific Corporation (BSX) Investor Outlook: Unlocking a 17.33% Potential Upside in the Medical Devices Sector

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector, is making waves in the medical devices industry with its innovative solutions and robust growth..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a Healthcare Behemoth with a 7.69% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to attract investor attention with its robust market presence and consistent performance. As a..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a Potential 214% Upside in CNS Disorder Treatments

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors with its potential for significant upside, as it continues to make strides in the biopharmaceutical..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a Potential 248.88% Upside

MBX Biosciences, Inc. (MBX) is making waves in the biotechnology sector as a clinical-stage biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders...

Precigen, Inc. (PGEN) Stock Analysis: Unpacking the 303% Upside Potential

Investors with a keen interest in biotechnology stocks will find Precigen, Inc. (NASDAQ: PGEN) a compelling case for analysis. With a market capitalization of $448.67 million..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a 126% Potential Upside Amidst Market Challenges

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, is garnering attention from investors due to its significant potential upside...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds